#pharmaceuticals - Deepdata

Deepdata

Register

Home

Discover

#pharmaceuticals

News Life

Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight

0 34 0

News Stocks

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Up 7.7% Following Analyst Upgrade

0 36 0

News Stocks

Amylyx Pharmaceuticals (NASDAQ:AMLX) Coverage Initiated at TD Cowen

0 77 0

News Entertainment

‘Pharmageddon’ Documentary Addresses Pharmaceutical Industry Concerns

0 79 0

News Stocks

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

0 100 0

News Science

SystImmune, Inc. to Present New izalontamab brengitecan (iza-bren) Data in Small Cell Lung Cancer and Non-Small Cell Lung Cancer with Driver Genomic Alterations (GA) outside of Classic EGFR Mutations at ASCO Congress 2025

0 37 0

News Political

Bill giving ivermectin special status clears House

0 100 0

News Science

Hypofibrinogenemia Market Set to Grow as New Treatments Emerge During the Forecast Period (2025–2034) | DelveInsight

0 22 0

News Stocks

Dimensional Fund Advisors LP Cuts Stock Position in Actinium Pharmaceuticals, Inc. (NYSE:ATNM)

0 57 0

News Stocks

Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

0 47 0

News Political

Commentary: Tariffs on meds will make America sick

0 35 0

News Life

Novo Nordisk Forges Multiple Partnerships To Sell Obesity Drug Wegovy At A Discount

0 68 0

News Stocks

PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1.7% – Still a Buy?

0 58 0

News Science

Meningococcal Vaccines Market Size to Surpass $9.05 Billion, Globally, by 2032 at 10.4% CAGR: Coherent Market Insights

0 29 0

News Science

Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development

0 93 0

News Stocks

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Bought by American Century Companies Inc.

0 102 0

News Science

All generic drugs are not created equal, study finds | What's the Deal?

0 105 0

News Stocks

Schroder Investment Management Group Trims Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

0 54 0

News Political

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

0 30 0

News Science

Connect Bio Eyeing Commercial Partner for Inflammatory Disease Treatment

0 118 0